Registro:

Referencias:

• Alfrey, A.C., Le Gendre, G.R., Kaehny, W.D., The dialysis encephalopathy syndrome. Possible aluminum intoxication (1976) N. Engl. J. Med., 294, pp. 184-188
• Kaehny, W.D., Hegg, A.P., Alfrey, A.C., Gastrointestinal absorption of aluminum from aluminum-containing antacids (1977) N. Engl. J. Med., 296, pp. 1389-1390
• Nordal, K.P., Dahl, E., Halse, J., Aksnes, L., Thomassen, Y., Flatmark, A., Aluminum metabolism and bone histology after kidney transplantation: A one-year follow-up study (1992) J. Clin. Endocrinol. Metab., 74, pp. 1140-1145
• O'Hare, J.A., Murnaghan, D.J., Reversal of aluminum-induced hemodialysis anemia by a low-aluminum dialysate (1982) N. Engl. J. Med., 306, pp. 654-656
• Wills, M.R., Savory, J., Aluminum poisoning. Dialysis encephalopathy, osteomalacia, and anemia (1983) Lancet, 2, pp. 29-34
• Cannata, J.B., Briggs, J.D., Junor, B.J.R., Fell, G.S., Beastall, G., Effect of aluminium overload on calcium and parathyroid-hormone metabolism (1983) Lancet, 1, pp. 501-503
• Joffe, P., Olsen, F., Heaf, J.G., Gammelgaard, B., Pödenphant, J., Aluminum concentrations in serum, dialysate, urine and bone among patients undergoing continuous ambulatory peritoneal dialysis (CAPD) (1989) Clin. Nephrol, 32, pp. 133-138
• Arieff, A.I., Cooper, J.D., Armstrong, D., Lazarowitz, V.C., Dementia, renal failure, and brain aluminum (1979) Ann. Intern. Med., 90, pp. 741-747
• Lin, J.-L., Lim, P.-S., Leu, M.-L., Relationship of body iron status and serum aluminum in chronic renal insufficiency patients not taking any aluminum-containing drugs (1995) Am. J. Nephrol., 15, pp. 118-122
• Poisson, M., Mashaly, R., Lebkiri, B., Dialysis encephalopathy: Recovery after interruption of aluminum intake (1978) Br. Med. J., 4, pp. 1610-1611
• Smith, P.S., McClure, J., Localization of aluminium by histochemical and electron probe X-ray microanalytical techniques in bone tissue of cases of renal osteodystrophy (1982) J. Clin. Pathol., 35, pp. 1283-1293
• Ellis, H.A., McCarthy, J.H., Herrington, J., Bone aluminium in haemodialysed patients and in rats injected with aluminium chloride: Relationship to impaired bone mineralization (1979) J. Clin. Pathol., 32, pp. 832-844
• Sherrard, D.J., Hercz, G., Pei, Y., The spectrum of bone disease in end-stage renal failure. An evolving disorder (1993) Kidney Int., 43, pp. 436-442
• Maloney, N.A., Ott, S.M., Alfrey, A.C., Miller, N.L., Coburn, J.W., Sherrard, D.J., Histological quantitation of aluminium in iliac bone from patients with renal failure (1982) J. Lab. Clin. Med., 99, pp. 206-216
• Bia, M.J., Cooper, K., Schnall, S., Aluminum induced anemia: Pathogenesis and treatment in patients on chronic hemodialysis (1989) Kidney Int., 36, pp. 852-858
• Eschbach, J.W., Adamson, J.W., Anemia in renal disease (1994) Diseases of the Kidney, pp. 2743-2758. , Schrier RW, Gottschalk CW (eds.) Little, Brown & Co., Boston
• Varet, B., Casadevall, N., Lacombe, C., Nayeaux, P., Erythropoietin: Physiology and Clinical Experience (1990) Semin. Hematol., 27, pp. 25-31
• Garbossa, G., Gutnisky, A., Nesse, A., Depressed erythroid progenitor cell activity in aluminum-overloaded mice (1996) Miner. Electrolyte Metab., 22, pp. 214-218
• Touam, M., Martínez, F., Lacour, B., Aluminium-induced reversible microcytic anemia in experimental chronic renal failure: Clinical and experimental studies (1983) Clin. Nephrol., 19, pp. 295-298
• Kaiser, L., Schwartz, K.A., Burnatowska-Hledin, M.A., Mayor, G.H., Microcytic anemia secondary to intraperitoneal aluminum in normal and uremic rats (1984) Kidney Int., 26, pp. 269-274
• Garbossa, G., Gutnisky, A., Nesse, A., The inhibitory action of aluminum on mouse bone marrow cell growth: Evidence for an erythropoietin- And transferrin-mediated mechanism (1994) Miner. Electrolyte Metab., 20, pp. 141-146
• Mladenovic, J., Aluminum inhibits erythropoiesis in vitro (1988) J. Clin. Invest., 81, pp. 1661-1665
• Moody, J.R., Lindstrom, R.M., Selection and cleaning of plastic containers for storage of trace element samples (1977) Anal. Chem., 49, pp. 2264-2267
• Ormrod, D., Miller, T., Experimental uremia. Description of a model producing varying degrees of stable uremia (1980) Nephron, 26, pp. 249-254
• Velarde, F., Monge, C., Vidal, A., Carcagno, M., Criscuolo, M., Bozzini, C., Serum immunoreactive erythropoietin in high altitude natives with and without excessive erythrocytosis (1991) Exp. Hematol., 19, pp. 257-260
• Drüeke, T., Lacour, B., Touam, M., Basile, C., Bourdon, R., Oral aluminum administration to uremic, hyperparathyroid, or vitamin D-supplemented rats (1985) Nephron, 39, pp. 10-17
• Recker, R., Blotcky, A.J., Leffler, J.A., Rack, E.P., Evidence for aluminum absorption from the gastrointestinal tract and bone deposition by aluminum carbonate ingestion with normal real function (1977) J. Lab. Clin. Med., 90, pp. 810-815
• Kaye, M., Bone marrow aluminium storage in renal failure (1983) J. Clin. Pathol., 36, pp. 1288-1291
• Drücke, T.B., Lacour, B., Touam, M., Effect of aluminum on hematopoiesis (1986) Kidney Int., 29 (18 SUPPL.), pp. S45-8
• Alfrey, A.C., Phosphate, aluminum, and other elements in chronic renal disease (1994) Diseases of the Kidney, pp. 3153-3166. , Schrier RW, Gottschalk CW (eds). Little Brown 6k Co., Boston
• Mera, S.L., Aluminium, amyloid, and Alzheimer's disease (1991) Med. Labor. Sci., 48, pp. 283-295
• Goodman, W.G., Leite Duarte, M.E., Aluminum: Effects on bone and role in the pathogenesis of renal osteodystrophy (1991) Miner. Electrolyte Metab., 17, pp. 221-232

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------